WallStreetZenWallStreetZen

NYSEMKT: PHGE
Biomx Inc Stock Ownership - Who owns Biomx?

Insider buying vs selling

Have Biomx Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Assaf OronChief Business Officer2023-11-293,414$0.35
$1.19kSell
Assaf OronChief Business Officer2023-11-295,444$0.40
$2.18kSell
Assaf OronChief Business Officer2023-11-292,056$0.34
$699.04Sell
Assaf OronChief Business Officer2023-05-223,192$0.27
$871.42Buy
Assaf OronChief Business Officer2023-05-196,521$0.28
$1.83kBuy
Assaf OronChief Business Officer2023-05-181,201$0.27
$327.87Buy

1 of 1

PHGE insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHGE insiders and whales buy or sell their stock.

PHGE Shareholders

What type of owners hold Biomx Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn11.06%6,110,098$1.92MInsider
Erez Chimovits8.38%4,626,978$1.46MInsider
Fibrosis Foundation Cystic8.24%4,552,315$1.43MInsider
Orbimed Advisors LLC8.18%4,517,589$1.42MInstitution
Orbimed Israel Biofund GP Limited Partnership5.73%3,161,489$995.87kInsider
Chidozie Ugwumba5.43%2,997,025$944.06kInsider
Takeda Pharmaceutical Co Ltd4.47%2,470,935$778.34kInsider
Johnson Johnson3.86%2,133,402$672.02kInstitution
Jonas Grossman3.77%2,080,217$655.27kInsider
8vc GP I LLC1.97%1,086,191$342.15kInstitution

1 of 3

PHGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHGE14.70%48.14%Net Buying
NERV6.78%93.22%Net Selling
NRBO0.25%99.75%
PIRS38.94%4.72%Net Buying
DOMH7.25%92.75%Net BuyingNet Buying

Biomx Stock Ownership FAQ

Who owns Biomx?

Biomx (NYSEMKT: PHGE) is owned by 14.70% institutional shareholders, 48.14% Biomx insiders, and 37.16% retail investors. James E. Flynn is the largest individual Biomx shareholder, owning 6.11M shares representing 11.06% of the company. James E. Flynn's Biomx shares are currently valued at $1.92M.

If you're new to stock investing, here's how to buy Biomx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.